Australia, July 29 -- CG Oncology Inc., owns the trademark (2508792) for 'CG ONCOLYTIC IMMUNOTHERAPY' and 'RING,INCOMPLETE & ENDLESS-BELT,NOTCHED-SIDE,DIVIDED FORM LTRS CG,INTERLOCKING.' till Dec. 20, 2034.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune disease...